Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)

Addiction. 2019 Mar;114(3):571-572. doi: 10.1111/add.14495. Epub 2019 Jan 22.

Authors

Shalini Arunogiri^{1

2}, Rose Crossin^{1

2}, Debbie Scott^{1

2}, Dan I Lubman^{1

2}

Affiliations

¹ Turning Point, Eastern Health, Richmond, VIC, Australia.
² Eastern Health Clinical School, Monash University, Box Hill, VIC, Australia.

PMID: 30672047
DOI: 10.1111/add.14495

No abstract available

Keywords: Abuse; gabapentinoid; harms; misuse; poisoning; pregabalin; prescription.

Publication types

Letter
Comment

MeSH terms

Australia
Cyclohexanecarboxylic Acids*
Pregabalin
Prescription Drugs*
gamma-Aminobutyric Acid

Substances

Cyclohexanecarboxylic Acids
Prescription Drugs
Pregabalin
gamma-Aminobutyric Acid